
Why Series A Health-Techs Lose 6 Months Trying to Hire Their First Sales Rep
A direct look at the six-month failure pattern that derails Series A health-tech commercial plans, and what to do instead.
Explore the latest insights and updates on the medical sales industry through our MDliaison blog. We cover trends, challenges, and innovations shaping the sector, offering valuable information for professionals and companies alike. Stay informed and ahead in the ever-evolving medical sales industry with our expert analysis and industry news.

A direct look at the six-month failure pattern that derails Series A health-tech commercial plans, and what to do instead.

A look at the math on testing new geographic territories with contract reps before committing to W2 hires at Series A.

Field notes from Series A health-tech VPs of Commercial preparing the provider traction slide for the Series B deck.

A decision framework for Series A health-tech VPs of Commercial weighing W2 reps, fractional sales leaders, and contract field forces against a 12-month runway.

Commission-based 1099 medical sales reps and AKS risk in 2025. What 42 U.S.C. § 1320a-7b(b) and 42 C.F.R. § 1001.952(d) require, what Sorensen and Marchetti changed, and what legal teams should document.

A practical framework for choosing a first digital health sales hire: W2 rep, fractional VP of Sales, or contracted field rep by stage, budget, and traction timeline.